FOR AUTHORS
Search
Search Results
Found 14 items.
-
Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trial
Published: December 27, 20231825pdf: 301HTML: 10 -
Clinical trial design, endpoints and regulatory considerations in heart failure
Published: March 28, 20245143PDF: 239HTML: 69 -
Defining iron replete status in patients with heart failure treated with intravenous iron
Published: December 21, 20232062pdf: 150HTML: 28 -
The scientific targets: the myocardium, the vasculature and the body’s response to heart failure
Published: March 28, 20242203PDF: 75HTML: 14 -
Rationale and design for the peripartum cardiomyopathy in Nigeria (PEACE) registry
Published: November 28, 2023656pdf: 96HTML: 10 -
Acute interventional management of spontaneous coronary artery dissection: case series and literature review
Published: March 28, 20242957PDF: 99HTML: 19 -
Intervention options: depression and cardiovascular disease during COVID-19
Published: November 28, 20231354pdf: 102HTML: 2 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
Published: November 23, 2023714pdf: 123Supplementary Material: 19HTML: 19 -
Evolving targets for heart failure: the journey so far
Published: November 28, 20231519pdf: 128HTML: 4 -
Adherence to lifestyle therapy in patients with chronic heart failure and comorbidity
Published: December 20, 2023779pdf: 89HTML: 5 -
Using multiple primary endpoints in clinical trials with a focus on heart failure
Published: June 28, 20244034PDF: 475 -
To clip or not to clip moderate-to-severe functional mitral regurgitation in patients with heart failure?
Published: November 5, 20242708PDF: 650 -
Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378
Published: December 30, 20241330pdf: 431
1 - 14 of 14 items